Litigation Details for Biogen International GmbH v. Amneal Pharmaceuticals LLC (D. Del. 2017)
✉ Email this page to a colleague
Biogen International GmbH v. Amneal Pharmaceuticals LLC (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-06-26 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
Jury Demand | Defendant | Referred To | |
Patents | 6,509,376; 7,320,999; 7,619,001; 8,399,514; 8,759,393 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Biogen International GmbH v. Amneal Pharmaceuticals LLC
Details for Biogen International GmbH v. Amneal Pharmaceuticals LLC (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-03-07 | 236 | Opinion - Memorandum Opinion | alleging infringement of U.S. Patent Nos. 6,509,376 ("the ' 376 patent"), 7,320,999 ("the… 514 patent") (collectively, "patents-in-suit" or "asserted patents"). …;the ' 999 patent"), 7,619,001 ("the ' 001 patent"), 7,803 ,840 ("the '…#39; 840 patent"), 8,759,393 ("the ' 393 patent"), and 8,399,514 ("the ' 514…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |